
Search Results for compounds
Searching compounds for 1,3 3,3 6 returned 1132 results.
Displaying compounds 651 - 675 of 1132 in total
T3D3953
79-57-2
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboximidic acid
Matched synonyms: … 6153-64-6 (Di-hydrate) …
T3D1593
10025-98-6
T3D3039
56-29-1
T3D3090
4720-09-6
3,4,6,9,14-pentahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate
T3D3102
28772-56-7
3-{3-[4-(4-bromophenyl)phenyl]-3-hydroxy-1-phenylpropyl}-2-hydroxy-4H-chromen-4-one
Matched treatment: … slow intravenous injections of 10-25 mg repeated all 3-6 hours until normalisation of the …
T3D3741
536-69-6
T3D4030
81720-10-7
3-{8-[(3E)-4-[6'-(3-{3,11-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl}-1-hydroxybutyl)-8'-hydroxy-7'-methylidene-hexahydro-3'H-spiro[oxolane-2,2'-pyrano[3,2-b]pyran]-5-yl]but-3-en-2-yl]-5-hydroxy-10-methyl-1,7-dioxaspiro[5.5]undec-10-en-2-yl}-2-hydroxy-2-methylpropanoic acid
T3D4177
124505-87-9
(2S)-2-amino-6-(2-{[(4S)-4-amino-4-carboxybutyl]imino}-1H,2H,4H-imidazo[4,5-b]pyridin-4-yl)hexanoic acid
Matched description: … advanced glycation end-products (AGE) in tissue proteins, N(6)-carboxymethyllysine and pentosidine …
Matched synonyms: … (2S)-2-amino-6-(2-{[(4S)-4-amino-4-carboxybutyl]amino}-4H-imidazo[4,5-b]pyridin-4-yl)hexanoic acid ... 6-(2-{[(4S)-4-Amino-4-carboxybutyl]amino}-4H-imidazo[4,5-b]pyridin-4-yl)-L-norleucine …
Matched synonyms: … (2S)-2-amino-6-(2-{[(4S)-4-amino-4-carboxybutyl]amino}-4H-imidazo[4,5-b]pyridin-4-yl)hexanoic acid ... 6-(2-{[(4S)-4-Amino-4-carboxybutyl]amino}-4H-imidazo[4,5-b]pyridin-4-yl)-L-norleucine …
T3D4506
114369-43-6
T3D4619
99-19-4
(2S)-2-phenyl-2-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile
T3D4852
1260-17-9
3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-9,10-dihydroanthracene-2-carboxylic acid
T3D4883
111-20-6
T3D4909
122-57-6
T3D1263
892-20-6
T3D2566
9005-49-6
(2R,3S,4S,5R)-3-{[(2S,3R,4S,5S,6S)-5-{[(2R,3R,4R,5S,6S)-6-carboxy-5-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-3,4-dihydroxyoxan-2-yl]oxy}-6-hydroxy-4-(sulfomethyl)-3-(sulfooxy)oxan-2-yl]oxy}-4,6-dihydroxy-5-(sulfooxy)oxane-2-carboxylic acid
T3D2742
2180-92-9
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboximidic acid
Matched toxicity: … arterial plasma concentration of 4.5 mcg/mL.
LD50: 6 to 8 mg/kg (intravenous, mice)
LD50: 38 to 54 mg/kg (subcutaneous, mice) …
Matched synonyms: … 1-Butyl-2',6'-pipecoloxylidide ... dl-1-Butyl-2',6'-pipecoloxylidide …
Matched synonyms: … 1-Butyl-2',6'-pipecoloxylidide ... dl-1-Butyl-2',6'-pipecoloxylidide …
T3D2788
18883-66-4
(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)-N-methyl-N-nitrosooxane-3-carbamimidic acid
T3D3101
56073-10-0
3-{3-[4-(4-bromophenyl)phenyl]-1,2,3,4-tetrahydronaphthalen-1-yl}-2-hydroxy-4H-chromen-4-one
Matched treatment: … slow intravenous injections of 10-25 mg repeated all 3-6 hours until normalisation of the …